Logo de la Universdad de ValenciaLogo CSIC Logo del portal

Haga clic para ver las últimas publicaciones en Pubmed

2021

  • Mattenberger F, Vila-Nistal M, Geller R. Increased RNA virus population diversity improves adaptability. doi: 10.21203/rs.3.rs-118637/v1.
  • Mattenberger F, Latorre V, Tirosh O, Stern A, Geller R. Globally defining the effects of mutations in a picornavirus capsid. Elife. 2021 Jan 12;10:e64256. doi: 10.7554/eLife.64256.
  • Valdivia A, Torres I, Latorre V, Francés-Gómez C, Albert E, Gozalbo-Rovira R, Alcaraz MJ, Buesa J, Rodríguez-Díaz J, Geller R, Navarro D. Inference of SARS-CoV-2 spike-binding neutralizing antibody titers in sera from hospitalized COVID-19 patients by using commercial enzyme and chemiluminescent immunoassays. Eur J Clin Microbiol Infect Dis. 2021 Jan 6:1–10.

2020

  • Valdivia A, Torres I, Latorre V, Francés-Gómez C, Ferrer J, Forqué L, Costa R, de la Asunción CS, Huntley D, Gozalbo-Rovira R, Buesa J, Giménez E, Rodríguez-Díaz J, Geller R, Navarro D. Suitability of two rapid lateral flow immunochromatographic assays for predicting SARS-CoV-2 neutralizing activity of sera. J Med Virol. 2020 Nov 25:10.
  • Siles-Lucas M, González-Miguel J, Geller R, Sanjuan R, Pérez-Arévalo J, Martínez-Moreno Á. Potential Influence of Helminth Molecules on COVID-19 Pathology. Trends Parasitol. 2021 Jan;37(1):11-14. doi:10.1016/j.pt.2020.10.002. Epub 2020 Oct 15.
  • Gozalbo-Rovira R, Gimenez E, Latorre V, Francés-Gómez C, Albert E, Buesa J, Marina A, Blasco ML, Signes-Costa J, Rodríguez-Díaz J, Geller R, Navarro D. SARS-CoV-2 antibodies, serum inflammatory biomarkers and clinical severity of hospitalized COVID-19 patients. J Clin Virol. 2020 Oct;131:104611.

2019

  • Bou JV, Geller R, Sanjuán R. Membrane-Associated Enteroviruses Undergo Intercellular Transmission as Pools of Sibling Viral Genomes. Cell Rep. 2019 Oct 15;29(3):714-723.

2018

  • Latorre V*, Mattenberger F*, Geller R. Chaperoning the Mononegavirales: Current Knowledge and Future Directions. Viruses 2018, 10(12), 699
  • Geller R*, Pechmann S*, Acevedo A, Andino R, Frdyman J. Hsp90 shapes protein and RNA evolution to balance trade-offs between protein stability and aggregation. Nature Communications

2017

  • Geller R*, Pechmann S*, Acevedo A, Andino R, Frdyman J. Hsp90 dictates viral sequence space by balancing the evolutionary tradeoffs between protein stability, aggregation and translation rate. BioRxiv

2016

  • Geller R, Estada U, Peris JB, Andreu I, Bou JV, Garijo R, Cuevas JM, Sabariegos R, Mas A, Sanjuán R. The hepatitis C virus genome exhibits highly heterogeneous mutation rates. Nat Microbio. 2016 Apr 18

2015

  • Combe M, Garijo R, Geller R, Cuevas JM, Sanjuán R. Single-Cell Analysis of RNA Virus Infection Identifies Multiple Genetically Diverse Viral Genomes within Single Infectious Units. Cell Host Microbe. 2015 Oct 14;18(4):424-32
  • Geller R*, Domingo-Calap P*, Cuevas JM*, Rossolillo P, Negroni M, Sanjuán R. The external domains of the HIV-1 envelope are a mutational cold spot. Nat Commun. 2015 Oct 9;6:8571. *Shared first authors
  • Cuevas JM*, Geller R*, Garijo R, López-Aldeguer J, Sanjuán R. Extremely High Mutation Rate of HIV-1 In Vivo. PLoS Biol. 2015 Sep 16;13(9):e1002252. *Shared first authors and highlighted in PLoS Biol

2013

  • Geller R, Andino R, Frydman J. Hsp90 Inhibitors Exhibit Resistance-Free Antiviral Activity against Respiratory Syncytial Virus. PLoS ONE. 2013 Feb 8(2); e56762

2012

  • Chan CT, Reeves RE, Geller R, Yaghoubi SS, Hoehne A, Solow-Cordero DE, Chiosis G, Massoud TF, Paulmurugan R, Gambhir SS. Discovery and validation of small-molecule heat-shock protein 90 inhibitors through multimodality molecular imaging in living subjects. PNAS. 2012 Sep 11;109(37):E2476-85

2011

  • Geller R, Taguwa S, Frydman J. (2011) Broad action of Hsp90 as a host chaperone required for viral replication. Biochim Biophys Acta. 2012 Mar;1823(3):698-706

2007

  • Geller R, Vignuzzi M, Andino R, Frydman J. (2007) Evolutionary constraints on chaperone-mediated folding provide an antiviral approach refractory to development of drug resistance. Genes Dev. 21 (2):195-205

2006

  • Mattenberger F, Vila-Nistal M, Geller R. Increased RNA virus population diversity improves adaptability. doi: 10.21203/rs.3.rs-118637/v1.
  • Tam S, Geller R, Spiess C, Frydman J. (2006) The chaperonin TRiC controls polyglutamine aggregation and toxicity through subunit-specific interactions. Nat Cell Biol. 8 (10):1155-62

2002

  • Khakoo SI, Geller R, Shin S, Jenkins JA, Parham P. (2002) The D0 domain of KIR3D acts as a major histocompatibility complex class I binding enhancer. J Exp Med. 196 (7):911-21
  • Geller R, Adams EJ, Guethlein LA, Little AM, Madrigal JA, Parham P. (2002) Linkage of Patr-AL to Patr-A and- B in the major histocompatibility complex of the common chimpanzee (Pan troglodytes). Immunogenetics 54 (3):212-5

Síguenos: Twitter Viral Biology